Zentalis Stock Financials

We strongly advise to harness Zentalis PharmaceuticalsL fundamental analysis to find out if markets are presently mispricing the firm. Specifically this technique allows you to validate available financial indicators of Zentalis PharmaceuticalsL as well as the relationship between them. We were able to interpolate and analyze data for twenty-seven available indicators for Zentalis PharmaceuticalsL, which can be compared to its rivals. To ensure the equity is not overpriced, please check out all Zentalis PharmaceuticalsL financials, including its ebitda, current ratio, as well as the relationship between the Current Ratio and number of employees .
With this module, you can analyze Zentalis financials for your investing period. You should be able to track the changes in Zentalis PharmaceuticalsL individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Zentalis PharmaceuticalsL Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zentalis PharmaceuticalsL's financial statements are interrelated, with each one affecting the others. For example, an increase in Zentalis PharmaceuticalsL's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 24
Zentalis PharmaceuticalsLlc has less than 24 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Zentalis PharmaceuticalsL stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Zentalis PharmaceuticalsL's official financial statements usually reflect Zentalis PharmaceuticalsL's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Zentalis PharmaceuticalsL. For example, before you start analyzing numbers published by Zentalis accountants, it's critical to develop an understanding of what Zentalis PharmaceuticalsL's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Zentalis PharmaceuticalsL's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zentalis PharmaceuticalsL's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Zentalis PharmaceuticalsL's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Zentalis PharmaceuticalsLlc. Please utilize our Beneish M Score to check the likelihood of Zentalis PharmaceuticalsL's management to manipulate its earnings.

Zentalis PharmaceuticalsL Company Summary

Zentalis PharmaceuticalsL competes with Capstone Copper, Snap On, Toro, Techtronic Industries, and Volvo AB. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. The company was incorporated in 2014 and is based in New York, New York. Zentalis Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 177 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address1359 Broadway, New
IndustryHealth Care
BenchmarkNYSE Composite
Phone212 433 3791
CurrencyUSD - US Dollar
You should never invest in Zentalis PharmaceuticalsL without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Zentalis Stock, because this is throwing your money away. Analyzing the key information contained in Zentalis PharmaceuticalsL's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Zentalis PharmaceuticalsL Key Financial Ratios

Generally speaking, Zentalis PharmaceuticalsL's financial ratios allow both analysts and investors to convert raw data from Zentalis PharmaceuticalsL's financial statements into concise, actionable information that can be used to evaluate the performance of Zentalis PharmaceuticalsL over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Zentalis PharmaceuticalsL reports annually and quarterly.

Zentalis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zentalis PharmaceuticalsL's current stock value. Our valuation model uses many indicators to compare Zentalis PharmaceuticalsL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zentalis PharmaceuticalsL competition to find correlations between indicators driving Zentalis PharmaceuticalsL's intrinsic value. More Info.
Zentalis PharmaceuticalsLlc is rated first in shares owned by insiders category among related companies. It is rated first in cash per share category among related companies fabricating about  1.05  of Cash per Share per Shares Owned by Insiders. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Zentalis PharmaceuticalsL by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zentalis PharmaceuticalsL's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zentalis PharmaceuticalsL's earnings, one of the primary drivers of an investment's value.
Check out Your Current Watchlist. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Other Tools for Zentalis Stock

When running Zentalis PharmaceuticalsL price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated